Many KDMs members, such as LSD1, KDM4A/B/C/D, KDM6A, and KDM7A, are associated with BC progress in a subtype/content-dependent manner, and inhibitors targeting them have been extensively developed [16–21]. The gene discussed is KDM1A; the disease is breast cancer.